Moolec Science (MLEC) Return on Sales (2022 - 2024)
Moolec Science (MLEC) reported Return on Sales of 0.01% for Q4 2024, up 6.0% on a YoY basis from 0.01% in Q1 2024, and up 25.35% sequentially from 0.01% in Q3 2024.
Moolec Science (MLEC) Return on Sales (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Return on Sales data on file, last reported at 0.01% in Q4 2024.
- For the quarter ending Q4 2024, Return on Sales rose 6.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2024 stood at 0.01% (down 1.0% YoY), and the FY2024 full-year result was 0.01%, up 56.0% from the prior year.
- Return on Sales advanced to 0.01% in Q4 2024, from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 50.18% in Q4 2022 to a low of 7.46% in Q2 2022.
- A 3-year average of 3.65% and a median of 0.01% in 2023 frame the typical range for Return on Sales.
- Peak annual rise in Return on Sales reached 746 bps in 2023, while the deepest fall reached 5025 bps in 2023.
- Tracing MLEC's Return on Sales over 3 years: stood at 50.18% in 2022, then plunged by 100 bps to 0.07% in 2023, then jumped by 87 bps to 0.01% in 2024.
- Business Quant data shows MLEC's Return on Sales at 0.01% in Q4 2024, 0.01% in Q3 2024, and 0.02% in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.13% |
| Dec 31, 2022 | 50.18% |
| Sep 30, 2022 | 0.63% |
| Jun 30, 2022 | -7.46% |
| Mar 31, 2022 | 0.44% |